PubMed HealthSearch

PubMed · 6587569

Gene-splicing experiment.

Abstract

In the article "Windows on a new cosmology" by George Lake (18 May, p. 675), the caption for figure 4(b) on page 680 was incorrect. The photograph shows the electric dipole moment apparatus at the Institute Laue-Langevin in Grenoble, France [courtesy of N. Ramsey].

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

T Suslow. 1984-07-13. Gene-splicing experiment.. https://doi.org/10.1126/science.225.4658.116-a

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A quantitative method for the determination of plasmid copy number in recombinant yeast.

A method is described for the determination of plasmid copy number (PCN) in the recombinant yeast Saccharomyces cerevisiae producing human coagulation Factor XIII. Southern hybridization of restriction endonuclease HindIII-digested total DNA from yeast transformant with the 32P-labelled URA3 gene as a probe detected two band: one corresponding to the chromosomal URA3 gene and the other corresponding to the recombinant plasmid. Thus, the present method using the genomic URA3 gene as an internal standard allowed an estimation of both the plasmid and the standard simultaneously. Since haploid yeast cells harbour one copy of genomic URA3 gene, the PCN can be determined as the ratio of the amount of plasmid to that of genomic URA3 gene. A linear relationship between the determined PCN and the plasmid content was observed ranging from 0.3 to 200 ng. The method is reproducible and independent of the extraction efficiency for the recombinant plasmid. The present method was successfully used to analyzed the PCN of a centromere-based plasmid YCp50 (= 2.7) and of a 2 microns-based plasmid pEMBLyex4 (= 112).

DNA, Recombinant

The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses.

We describe the construction and characterization of retroviral vectors and packaging plasmids that produce helper-free retrovirus with titers of 1 X 10(6) to 5 X 10(6) within 48 h. These vectors contain the immediate early region of the human cytomegalovirus enhancer-promoter fused to the Moloney murine leukemia virus long terminal repeat at the TATA box in the 5' U3 region, yielding the pCL promoter. By selecting vectors designed to express genes from one of four promoters (dihydrofolate reductase, Rous sarcoma virus, long terminal repeat, or cytomegalovirus), the pCL system permits the investigator to control the level of gene expression in target cells over a 100-fold range, while maintaining uniformly high titers of virus from transiently transfected producer cells. The pCL packaging plasmids lack a packaging signal (delta-psi) and include an added safety modification that renders them self-inactivating through the deletion of the 3' U3 enhancer. Ecotropic, amphotropic (4070A), and amphotropic-mink cell focus-forming hybrid (10A1) envelope constructions have been prepared and tested, permitting flexible selection of vector pseudotype in accordance with experimental needs. Vector supernatants are free of helper virus and are of sufficiently high titer within 2 days of transient transfection in 293 cells to permit infection of more than 50% of randomly cycling target cells in culture. We demonstrated the efficacy of these vectors by using them to transfer three potent cell cycle control genes (the p16(INK4A), p53, and Rb1 genes) into human glioblastoma cells.

DNA, Recombinant